Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results

被引：0

作者：

Mantegazza, Renato ^{[1
]}

Bril, Vera ^{[2
]}

Vu, Tuan ^{[3
]}

Karam, Chafic ^{[4
]}

Peric, Stojan ^{[5
]}

Margania, Temur ^{[6
]}

Murai, Hiroyuki ^{[7
]}

Bilinska, Malgorzata ^{[8
]}

Shakarishvili, Roman ^{[9
]}

Smilowski, Marek ^{[10
]}

Guglietta, Antonio ^{[11
]}

Ulrichts, Peter ^{[11
]}

Vangeneugden, Tony ^{[11
]}

Utsugisawa, Kimiaki ^{[12
]}

Verschuuren, Jan ^{[13
]}

Howard, James ^{[14
]}

机构：

[1] Fdn IRCCS Ist Neurol Carlo Besta, Neurol Iv Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy

[2] Univ Toronto, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada

[3] Univ S Florida, Morsani Coll Med, Neurol, Tampa, FL 33620 USA

[4] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA

[5] Univ Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia

[6] New Hosp, Dept Neurol & Neurorehabil, Tbilisi, Georgia

[7] Int Univ Hlth & Welf, Neurol, Tokyo, Japan

[8] Wroclaw Med Univ, Dept & Clin Neurol, Wroclaw, Poland

[9] Sarajishvili Inst Neurol & Neurosurg, Neurol, Tbilisi, Poland

[10] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland

[11] Argenx, Clin Dev, Ghent, Belgium

[12] Hanamaki Gen Hosp, Neurol, Hanamaki, Japan

[13] Leiden Univ, Med Ctr, Neurol, Leiden, Netherlands

[14] Univ N Carolina, Neurol, Chapel Hill, NC 27515 USA

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷

关键词：

D O I：

10.1016/j.jns.2021.117764

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

117764

引用

页数：1

共 50 条

[31] Efficacy and safety of Efgartigimod in patients with generalized myasthenia gravis: interim results of a prospective, single-arm, observational study in China
Liang, H.
Wang, P.
Zhang, B.
Zhao, C.
Huang, S.
NEUROMUSCULAR DISORDERS, 2023, 33 : S177 - S177
[32] Efgartigimod in Myasthenia Gravis: Phase 3 Trial Design
Howard, J. F., Jr.
De Haard, H.
Parys, W.
Ulrichts, P.
Guglietta, A.
Mantegazza, R. E.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 353 - 353
[33] STUDY DESIGN OF INTRAVENOUS EFGARTIGIMOD IN JUVENILE GENERALIZED MYASTHENIA GRAVIS
Kuntz, Nancy
Schwaede, Abigail
Bogatyreva, Anna
Podhorna, Jana
Steeland, Sophie
Van Bragt, Tonke
Van Hoorick, Benjamin
Guglietta, Antonio
Howard, James
MUSCLE & NERVE, 2022, 66 : S111 - S111
[34] STUDY DESIGN OF INTRAVENOUS EFGARTIGIMOD IN JUVENILE GENERALIZED MYASTHENIA GRAVIS
Kuntz, Nancy L.
Bogatyreva, Anna
Podhorna, Jana
Steeland, Sophie
Van Bragt, Tonke
Van Hoorick, Benjamin
Guglietta, Antonio
Howard, James F., Jr.
MUSCLE & NERVE, 2022, 65 : S12 - S13
[35] OBSERVED EFFICACY OF EFGARTIGIMOD IN GENERALIZED MYASTHENIA GRAVIS ACROSS PATIENT SUBGROUPS IN THE ADAPT-SC plus STUDY
Muppidi, Srikanth
Vu, Tuan
Bhavaraju-Sanka, Ratna
Brauer, Eddie
Kerstens, Rene
Utsugisawa, Kimiaki
Meisel, Andreas
MUSCLE & NERVE, 2024, 70 (03) : 703 - 703
[36] CONTINUOUS AND FIXED-CYCLE DOSING OF INTRAVENOUS EFGARTIGIMOD FOR GENERALIZED MYASTHENIA GRAVIS: STUDY DESIGN OF ADAPT NXT
Gwathmey, Kelly
Sahagian, Gregory
Hussain, Yessar
Feinberg, Marc
Habib, Ali
Skripuletz, Thomas
Ruck, Tobias
Rivner, Michael
Sun, Fang
Brauer, Edward
Gelinas, Deborah
Liu, Li
Podhorna, Jana
Mantegazza, Renato
MUSCLE & NERVE, 2022, 66 : S110 - S110
[37] CONTINUOUS AND FIXED-CYCLE DOSING OF INTRAVENOUS EFGARTIGIMOD FOR GENERALIZED MYASTHENIA GRAVIS: STUDY DESIGN OF ADAPT NXT
Sahagian, Gregory
Hussain, Yessar
Feinberg, Marc H.
Habib, Ali A.
Skripuletz, Thomas
Ruck, Tobias
Brauer, Edward
Gelinas, Deborah
Liu, Li
Podhorna, Jana
Mantegazza, Renato
MUSCLE & NERVE, 2022, 65 : S14 - S14
[38] Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
Sacca, Francesco
Barnett, Carolina
Vu, Tuan
Peric, Stojan
Phillips, Glenn A.
Zhao, Sihui
Qi, Cynthia Z.
Gelinas, Deborah
Chiroli, Silvia
Verschuuren, Jan J. G. M.
JOURNAL OF NEUROLOGY, 2023, 270 (04) : 2096 - 2105
[39] Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
Francesco Saccà
Carolina Barnett
Tuan Vu
Stojan Peric
Glenn A. Phillips
Sihui Zhao
Cynthia Z. Qi
Deborah Gelinas
Silvia Chiroli
Jan J. G. M. Verschuuren
Journal of Neurology, 2023, 270 : 2096 - 2105
[40] Additional Analyses of the Phase 2 Efgartigimod Study in Myasthenia Gravis
Howard, James
Bril, Vera
Mantegazza, Renato
Beydoun, Said
De Rivera Garrido, Fancisco Javier
Piehl, Fredrik
Rottoli, Maria Rosa
Van Damme, Philip
Vu, Tuan
Ulrichts, Peter
Guglietta, Antonio
Beauchamp, Jon
de Haard, Hans
Verschuuren, Jan
NEUROLOGY, 2020, 94 (15)

← 1 2 3 4 5 →